2018\u5e743\u670819\u65e5<\/p>\n
Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b Veeva)\u306f\u3001\u773c\u79d1\u95a2\u9023\u696d\u754c\u306e\u6700\u5927\u624bCRO\u3067\u3042\u308bOra, Inc.\u793e\uff08\u4ee5\u4e0bOra\u793e\uff09\u304c\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30b7\u30b9\u30c6\u30e0\u3084\u30d7\u30ed\u30bb\u30b9\u3092\u7d71\u5408\u5316\u3059\u308b\u305f\u3081Veeva Vault Clinical Suite<\/a><\/strong>\u3092\u63a1\u7528\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002Ora\u793e\u306f\u3001CTMS\u3001eTMF\u304a\u3088\u3073study start-up\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u7fa4\u3092\u5358\u4e00\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u307e\u3068\u3081\u308b\u3053\u3068\u3067\u3001\u81e8\u5e8a\u8a66\u9a13\u5168\u4f53\u306e\u696d\u52d9\u306e\u52b9\u7387\u5316\u3068\u53ef\u8996\u6027\u3092\u5411\u4e0a\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308aOra\u793e\u306f\u3001\u5185\u90e8\u306e\u95a2\u4fc2\u8005\u3068\u6cbb\u9a13\u4f9d\u983c\u8005\u3068\u306e\u9023\u643a\u3092\u62e1\u5927\u3057\u3066\u3001\u30b5\u30fc\u30d3\u30b9\u306e\u63d0\u4f9b\u3092\u8fc5\u901f\u5316\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u8cea\u3092\u9ad8\u3081\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n <\/p>\n Ora\u793e\u306e\u30af\u30ea\u30cb\u30ab\u30eb\u30a4\u30f3\u30d5\u30a9\u30e1\u30fc\u30b7\u30e7\u30f3\u30b7\u30b9\u30c6\u30e0\u30de\u30cd\u30b8\u30e3\u30fc\u3001Edward Leftin\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u79c1\u305f\u3061\u306b\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u5408\u7406\u5316\u3059\u308b\u65b0\u3057\u3044\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u304c\u5fc5\u8981\u3067\u3057\u305f\u3002Veeva\u306e\u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u958b\u767a\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u306e\u304a\u304b\u3052\u3067\u3001\u5f53\u793e\u306e\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306f\u4f5c\u696d\u52b9\u7387\u3092\u6539\u5584\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002\u73fe\u5728\u3067\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306b\u304a\u3051\u308b\u8a66\u9a13\u306e\u958b\u59cb\u304b\u3089\u7d42\u4e86\u307e\u3067\u306e\u3042\u3089\u3086\u308b\u30d7\u30ed\u30bb\u30b9\u3068\u60c5\u5831\u3092\u7ba1\u7406\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u300d<\/p>\n Ora\u793e\u306e\u7d71\u5408\u3055\u308c\u305f\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u79fb\u884c\u306f\u3001Veeva Vault eTMF<\/a><\/strong>\u304b\u3089\u59cb\u307e\u308a\u307e\u3057\u305f\u3002\u3053\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u3001TMF\u306e\u751f\u6210\u3068\u540c\u6642\u306b\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306b\u3088\u308b\u6587\u66f8\u3084\u30d7\u30ed\u30bb\u30b9\u306e\u7ba1\u7406\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u3067\u652f\u63f4\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u67fb\u5bdf\u306b\u5bfe\u3059\u308b\u6e96\u5099\u3092\u6574\u3048\u308b\u3068\u3068\u3082\u306b\u3001\u8a66\u9a13\u306e\u7d42\u4e86\u306b\u304b\u304b\u308b\u671f\u9593\u3092\u6570\u9031\u9593\u304b\u3089\u6570\u65e5\u9593\u306b\u307e\u3067\u77ed\u7e2e\u3057\u307e\u3059\u3002\u307e\u305fOra\u793e\u306f\u3001Veeva Vault Study Startup<\/strong><\/a><\/strong>\u306e\u8ffd\u52a0\u306b\u3088\u308a\u3001\u4e16\u754c\u4e2d\u306e\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u9078\u5b9a\u3068\u8a66\u9a13\u958b\u59cb\u307e\u3067\u306e\u30d7\u30ed\u30bb\u30b9\u3092\u8fc5\u901f\u5316\u3067\u304d\u305f\u307b\u304b\u3001\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306fVeeva Vault CTMS<\/a><\/strong>\u306b\u3088\u308a\u3001\u8a66\u9a13\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u3092\u901a\u3058\u3066\u5f93\u6765\u3088\u308a\u3082\u6709\u7528\u306a\u77e5\u898b\u3092\u7372\u5f97\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u30d7\u30ed\u30a2\u30af\u30c6\u30a3\u30d6\u306a\u81e8\u5e8a\u8a66\u9a13\u306e\u7ba1\u7406\u3092\u5b9f\u65bd\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n Veeva Vault Clinical Suite\u306f\u3001\u5404\u30c1\u30fc\u30e0\u304c\u540c\u3058\u8a66\u9a13\u6587\u66f8\u3084\u30c7\u30fc\u30bf\u3092\u5171\u6709\u3067\u304d\u308b\u3088\u3046\u652f\u63f4\u3059\u308b\u3053\u3068\u3067\u3001\u3088\u308a\u826f\u3044\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3048\u308b\u3088\u3046\u306b\u3057\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001Vault CTMS\u3084Vault Study Startup\u3067\u4f5c\u6210\u30fb\u767b\u9332\u3055\u308c\u305f\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u5831\u544a\u66f8\u3084CV\u306a\u3069\u306e\u6587\u66f8\u306f\u3001\u81ea\u52d5\u7684\u306bTMF\u306e\u4e00\u90e8\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u3046\u3057\u3066\u624b\u52d5\u306e\u30b9\u30c6\u30c3\u30d7\u3092\u6e1b\u3089\u3059\u4e00\u65b9\u3067\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3092\u542b\u3080\u8907\u6570\u7d44\u7e54\u306e\u30c1\u30fc\u30e0\u304c\u3001\u60c5\u5831\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306b\u6d3b\u7528\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n Veeva\u306eVeeva Vault\u62c5\u5f53\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Jennifer Goldsmith\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300cCRO\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u5316\u3057\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3068\u306e\u9593\u3067\u4eca\u307e\u3067\u4ee5\u4e0a\u306b\u5354\u50cd\u7684\u30fb\u6226\u7565\u7684\u306a\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u7bc9\u304f\u65b9\u5411\u3078\u5411\u304b\u3046\u696d\u754c\u5168\u4f53\u306e\u30c8\u30ec\u30f3\u30c9\u3092\u30ea\u30fc\u30c9\u3057\u3066\u3044\u307e\u3059\u3002Ora\u793e\u306f\u3001Veeva Vault Clinical Suite\u3067\u3069\u306e\u3088\u3046\u306b\u30b7\u30b9\u30c6\u30e0\u3068\u30d7\u30ed\u30bb\u30b9\u9593\u306e\u969c\u58c1\u3092\u6253\u958b\u3057\u3001\u8a66\u9a13\u5b9f\u65bd\u306e\u52b9\u7387\u5316\u3068\u54c1\u8cea\u306e\u6539\u5584\u3067\u304d\u308b\u306e\u304b\u3001\u6a21\u7bc4\u7684\u306a\u4e8b\u4f8b\u3092\u793a\u3057\u3066\u304f\u308c\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n Vault CTMS\u3001Vault eTMF\u3001\u304a\u3088\u3073Vault Study Startup\u306fVeeva Vault Clinical Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3001EDC\u3001CTMS\u3001eTMF\u304a\u3088\u3073study start-up\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u7fa4\u3092\u4e00\u3064\u306b\u307e\u3068\u3081\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3068\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u5316\u3059\u308b\u696d\u754c\u521d\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Vault Clinical\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u73fe\u5728\u3001\u4e16\u754c\u7684\u306b\u4e8b\u696d\u5c55\u958b\u3057\u3066\u3044\u308b\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u306e\u4e0a\u4f4d20\u793e\u306e\u3046\u30618\u793e\u3092\u542b\u3080\u3001170\u793e\u3092\u8d85\u3048\u308b\u304a\u5ba2\u69d8\u306b\u3054\u5229\u7528\u3044\u305f\u3060\u3044\u3066\u3044\u307e\u3059\u3002<\/p>\n <\/p>\n \u3010Veeva Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2018\u5e743\u670819\u65e5 Veeva Japan\u682a\u5f0f\u4f1a\u793e Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-41280","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-content-management","blog-product-veeva-rd","blog-product-veeva-vault"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41280"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=41280"}],"version-history":[{"count":2,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41280\/revisions"}],"predecessor-version":[{"id":41283,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41280\/revisions\/41283"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=41280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=41280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=41280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>Veeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067600\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended October 31, 2017. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"